Team:BIOSINT Mexico/kuxtal

From 2012e.igem.org

Revision as of 00:19, 28 October 2012 by YunuenZC (Talk | contribs)

Kuxtal

WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
Anthony Quinn was the first Mexican actor to win an Academy Award.
He deserved it for his role in the 1952 movie Viva Zapata.

The company

Business concept.

Kuxtal Biotech is a mexican young company founded by 16 biotechnology engineers that will provide solutions and genomic services to it's target market: biotechnology laboratories, college laboratories, medical and private institutions, and research centers. It is focused on customized gene synthesis, validation and technical assistance.

Business philosophy.

Kuxtal Biotech's mission is to improve the quality of life of all human beings by enhancing the production and supply of effective medicines and treatments that will make use of synthetic biology/biotechnology knowledge.

As our vision, In 2020, Kuxtal Biotech will be a recognized company in gene synthesis production and synthetic biology area because of the excellence in quality as well as early delivery time in all the products and services provided.

The values that Kuxtal will manage are:
a) Innovation-By generating new ideas and making them come true. The company will be always looking for new biotechnological processes and services to offer.
b) Team work-By promoting share of ideas, efficient communication and coordinate activities to reach common objectives.
c) Ethics ans realiability- By behaving in a honest and responsable way, always trying to satisfy our customers with useful services and products.

Services provided.

Kuxtal Biotech provides oligonucleotide synthesis services, as well as assessment and consulting services.

The synthesis services will be performed with the highest quality standards with the services provided by Kuxtal biotech as the fastest in the market, and the consulting services provided in real time. The main focus of the synthesis will be primer synthesis for PCR techniques for the range between 20 and 30 bp, however other services will be available such as RNA and DNA synthesis for antisense and silencing techniques.

Kuxtal biotech will be ready to deliver gene synthesis of complex traits in the vector that the customer specifies and of any length come time after, broadening the services offered to researchers.

Synthesis products will be delivered lyophilized in 2 mL vials on a dry-ice container, along with a certificate of analysis that ensures quality. The products should be resuspended prior use, or stored at -20°C if they are to be used within a year from the synthesis date. Shipping costs will be charged to the customer.

As part of the quality promise, Kuxtal Biotech will evaluate all orders submitted and provide feedback to its costumers whenever possible to ensure every synthesis meets the needs and expectations of the clients.

Competitive advantage.

The Kuxtal’s competitive advantage includes the offering of gene synthesis services within México, local production and commercialization, minimization of intermediaries and import regulatory bottlenecks, evasion of delays in delivery times and integral service (technical assistanece, quality product, efficient customer-supplier communication, customized attention).